Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393092 · ClinicalTrials.gov registry record · NA
Violence Prevention Study for Youth Age 10-15
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02393092: Clinical Trial NA study, sponsored by Virginia Commonwealth University.
NCT02393092 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02393092, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of a hospital-community based violence prevention pilot study designed to increase protective factors and reduce negative risk factors associated with violence of children aged 10-15. Behaviors and attitudes that relate to violence and behavior change will be assessed through a series of questionnaires administered in an interview format. Assessments will occur every nine weeks. Additionally, objective long term measures for violence related hospital visits, delinquency, and educational development will be obtained. The study will include the following interventions: 1. Brief violence prevention (BVP): a case manager administered psycho-educational intervention that will include an interactive discussion with youth regarding resources for remaining safe and preventing violence. The intervention will address the concerns and questions of youth and youth will be given information on how to access community based resources if needed. 2. Brief violence awareness (BVA): a packet of information about violence prevention and local community resources. 3. Emerging Leaders: East End: a semester (17 weeks) long curriculum based positive youth development education program held at the Boys and Girls Club of Metro Richmond, Martin Luther King Middle School site that includes case management to ensure continued engagement and participation. Specifically, it is hypothesized that: 1. Participants will report more positive youth behaviors as compared to their initial assessment. 2. Participants will report lower levels of risky youth behaviors compared to their initial assessment. 3. Participants will report increased interest in and knowledge of health professions. 4. Participants will report reduced levels of delinquency compared to their initial assessment. 5. Participants will report a reduction in the number of violence related hospital visits compared to the general 23223 population. 6. Hospital data will show a reduction in viol
Primary Outcome
The assessment contains select questions from the following: Future Aspirations - Peer Leader Survey, Rochester Youth Development Study, Individual Protective Factor Index, Center for Epidemiological Studies Depression Scale for Children, Attitude Toward Interpersonal Peer Violence Scale, Children's Exposure to Community Violence Scale, Self-Reported Delinquency Problem Behavior Frequency Scale, and CDC Youth Risk Behavior Surveillance System.
Interventions
- BEHAVIORAL Brief Violence Awareness
- BEHAVIORAL Brief Violence Prevention
- BEHAVIORAL Emerging Leaders: East End curriculum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-07-08 |
| Phase | NA |
Why NCT02393092 stopped before completion
NCT02393092 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Brief Violence Awareness is the first listed.
NCT02393092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02393092 about?
NCT02393092 is a clinical study titled "Violence Prevention Study for Youth Age 10-15". This study will evaluate the effectiveness of a hospital-community based violence prevention pilot study designed to increase protective factors and reduce negative risk factors associated with violence of children aged 10-15. Behaviors and attitudes that relate to violence and behavior change will ...
What is the current status of trial NCT02393092?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2015-07. Estimated completion is 2016-07-08.
What interventions are being tested in trial NCT02393092?
The interventions under investigation include: Brief Violence Awareness (BEHAVIORAL), Brief Violence Prevention (BEHAVIORAL), Emerging Leaders: East End curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT02393092?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02393092's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia